PFS Partners, LLC
- SEC CIK
- 0002002654
- Latest filing
- Jul 20, 2026
TRVI holding history
Trevi Therapeutics, Inc. in every 13F filed by PFS Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TRVI overviewAll 13F holders of TRVIFull Q2 2026 holdings
- Shares (Q2 2026)
- 79,000
- Value
- $1.47M
- % of portfolio
- 0.6%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 79,000 | $1.47M | 0.6% | 00.0% | Unchanged | Holders |
| Q1 2026 | 79,000 | $942.5K | 0.4% | 00.0% | Unchanged | Holders |
| Q4 2025 | 79,000 | $989.1K | 0.5% | 00.0% | Unchanged | Holders |
| Q3 2025 | 79,000 | $722.9K | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2025 | 79,000 | $432.1K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2025 | 79,000 | $496.9K | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2024 | 79,000 | $325.5K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2024 | 79,000 | $263.9K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2024 | 79,000 | $235.4K | 0.1% | −20,000−20.2% | Reduced | Holders |
| Q1 2024 | 99,000 | $341.6K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2023 | 99,000 | $132.7K | 0.1% | −1,000−1.0% | Reduced | Holders |
| Q3 2023 | 100,000 | $218.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2023 | 100,000 | $239.0K | 0.2% | +100,000 | New | Holders |